Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brooks Jackson

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
AIDS Research and Human Retroviruses|July 3, 2007
HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and DJessica D Church, Sarah E Hudelson, Laura A Guay, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2012
Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in AfricaKenneth Kintu, Philip Andrew, Philippa Musoke, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|October 13, 2021
Prevalence of maternal obesity at delivery and association with maternal and neonatal outcomesClaire Castaneda, Katharine Marsden, Timothy Maxwell, et al.
American Journal of Perinatology|February 21, 2021
SARS-CoV-2 Infection during Pregnancy in a Rural Midwest All-delivery Cohort and Associated Maternal and Neonatal OutcomesHaley A Steffen, Samantha R Swartz, J Brooks Jackson, et al.
JAMA|February 17, 2005
Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAARTRichard E Nettles, Tara L Kieffer, Patty Kwon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 10, 2011
Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY)Carolyne Onyango-Makumbi, Saad B Omer, Michael Mubiru, et al.
Journal of Clinical Microbiology|May 31, 2002
Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliterLisa M Demeter, Ronald J Bosch, Robert W Coombs, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 5, 2013
Immunogenicity of ALVAC-HIV vCP1521 in infants of HIV-1-infected women in Uganda (HPTN 027): the first pediatric HIV vaccine trial in AfricaPontiano Kaleebu, Harr Freeya Njai, Lei Wang, et al.
AIDS (London, England)|July 20, 2002
Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in UgandaLaura A Guay, Philippa Musoke, David L Hom, et al.
The Journal of Clinical Investigation|September 5, 2018
Short telomere syndromes cause a primary T cell immunodeficiencyChrista L Wagner, Vidya Sagar Hanumanthu, C Conover Talbot, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
AIDS Research and Human Retroviruses|July 3, 2007
HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and DJessica D Church, Sarah E Hudelson, Laura A Guay, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2012
Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in AfricaKenneth Kintu, Philip Andrew, Philippa Musoke, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|October 13, 2021
Prevalence of maternal obesity at delivery and association with maternal and neonatal outcomesClaire Castaneda, Katharine Marsden, Timothy Maxwell, et al.
American Journal of Perinatology|February 21, 2021
SARS-CoV-2 Infection during Pregnancy in a Rural Midwest All-delivery Cohort and Associated Maternal and Neonatal OutcomesHaley A Steffen, Samantha R Swartz, J Brooks Jackson, et al.
JAMA|February 17, 2005
Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAARTRichard E Nettles, Tara L Kieffer, Patty Kwon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 10, 2011
Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY)Carolyne Onyango-Makumbi, Saad B Omer, Michael Mubiru, et al.
Journal of Clinical Microbiology|May 31, 2002
Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliterLisa M Demeter, Ronald J Bosch, Robert W Coombs, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 5, 2013
Immunogenicity of ALVAC-HIV vCP1521 in infants of HIV-1-infected women in Uganda (HPTN 027): the first pediatric HIV vaccine trial in AfricaPontiano Kaleebu, Harr Freeya Njai, Lei Wang, et al.
AIDS (London, England)|July 20, 2002
Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in UgandaLaura A Guay, Philippa Musoke, David L Hom, et al.
The Journal of Clinical Investigation|September 5, 2018
Short telomere syndromes cause a primary T cell immunodeficiencyChrista L Wagner, Vidya Sagar Hanumanthu, C Conover Talbot, et al.
Pageof 14